启迪药业: 关于控股股东所持公司股份被司法拍卖的进展公告

Group 1 - The core point of the news is that the controlling shareholder of Qidi Pharmaceutical, Qidi Technology Service Co., Ltd., has auctioned off 58,606,962 shares, which represents 24.47% of the company's total share capital, potentially leading to a change in control of the company [1][5]. - The auction of the shares was initially scheduled for November 28, 2024, but was postponed due to objections from interested parties [3]. - The shares were successfully auctioned, but the final transfer of ownership is pending confirmation from the Beijing Financial Court [1][3]. Group 2 - Prior announcements regarding the potential judicial auction of the controlling shareholder's shares were made on October 30, 2024, and further updates were provided on June 17, 2025 [2][3]. - If the auctioned shares are fully transferred, Qidi Technology Service will no longer hold any shares in the company, and its voting rights will decrease significantly to 1.90% of the total share capital [5]. - The company emphasizes that the auction will not have a significant impact on its operations or governance, as it remains independent from the controlling shareholder [5].